14 results
To determine whether SRT achieves a local control rate comparable to surgery in patients with metastatic lung disease.
Primairy objective: we will examine the difference in VOC pattern of exhaled air between patients with histology-confirmed diagnoses of non small cell lung cancer vs breast cancer. Secundairy objective: a. to confirm the potential of the electronic…
The primary objective is to demonstrate superiority in overall survival of amrubicin (40 mg/m2 administered as a 5-minute infusion once daily for 3 consecutive days starting on Day 1 of a 21-day course) compared with topotecan hydrochloride (…
This study aims to compare the accuracy of staging with integrated PET-CT and EUS-FNA and/or EBUS-TBNA in patients with operable non-small cell lung cancer compared to perioperative mediastinal lymph node dissection/ systematic lymph node sampling.
To validate FDG-PET segmentation tools for radiation target volume definition by correlation of CT and FDG-PET volume measurements with histology of nodal metastases of squamous cell carcinoma of the head and neck.
1 The primary objective is to investigate whether the eNose can discriminate the smellprints obtained before and after 1 cycle of chemotherapy in patients with specific histological types of lung cancer (NSCLC: adenocarcinoma, squamous cell…
Main:the objective of this randomized trial would be to study disease free survival (DFS) in a population with completely resected NSCLC with homolateral lymph node mediastinal involvement histological or cytological proven. Who will randomly be…
To find correlations between tumour dimensions obtained by thresholds of uptake (SUV), metabolism (MRglu) or modelled thresholds (RTL) as measured during dynamic acquisition and anatomic (CT) and pathological data. Secondary objectives are the…
The objective of the present study is to investigate whether a metabolic response as assessed by 18F-FDG PET can be observed after the first fraction of SBRT. This study will contribute to establishing the role of definitive SBRT in the treatment of…
Establish the clinical value of a molecular sputum test for the diagnosis of lung cancer.
Development of a new technics to improve the diagnostic value of an EUS procedure in combination with reducing the amount of biopsies.
To assess tumor reponse with FDG-PET-CT imaging early after start of concomitant chemo-radiotherapy in relation to cytological, histological and biological tumor characteristics. The ultimate goal is to reveal more insight in tumor reponse assesment…
To determine toxicity of selective pulmonary artery perfusion (SPAP) for the treatment of non small cell lung cancer.
1. To determine the diagnostic accuracy of the electronic nose in the identification of lung cancer in new (referred for suspicion of lung cancer) patients based on the algorithm developed in the SCENT study part 1 (training-set).2. To determine the…